ストックスクリーナーアプリを入手
4.48
13.71%
0.54
アフターアワーズ：
4.50
0.02
+0.45%
前日終値:
$3.94
開ける：
$4.02
24時間の取引高:
80,467
Relative Volume:
1.93
時価総額：
$6.67M
収益：
$59.11M
当期純損益:
$-33.38M
株価収益率:
-0.025
EPS:
-178.995
ネットキャッシュフロー:
$-26.04M
1週間 パフォーマンス:
-6.10%
1か月 パフォーマンス:
+7.43%
6か月 パフォーマンス:
-36.72%
1年 パフォーマンス:
-74.63%
1日の値動き範囲:
$4.02
$4.87
1週間の範囲:
$3.4791
$5.02
52週間の値動き範囲:
$2.5211
$38.52
Dna X Inc Stock (SONM) Company Profile
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
4.48 | 5.86M | 59.11M | -33.38M | -26.04M | -179.00 |
MSFT
Microsoft Corp
|
418.57 | 3.11T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
192.08 | 545.79B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
136.88 | 329.43B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
663.46 | 165.00B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
524.74 | 96.54B | 8.00B | 1.10B | 2.28B | 6.4708 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-10-31 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-07-18 | 開始されました | B. Riley FBR | Buy |
| 2019-07-09 | アップグレード | National Securities | Neutral → Buy |
| 2019-06-10 | 開始されました | National Securities | Neutral |
| 2019-06-04 | 開始されました | Lake Street | Buy |
| 2019-06-04 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Dna X Inc (SONM) 最新ニュース
DNA X Inc. (SONM) Surges 13% as Buyer Demand Tests Key Resistance at $4.68Institutional Grade Picks - Newser
Ginkgo Bioworks Holdings Inc (DNA): What’s the Future of Autonomous Lab? - Yahoo Finance Singapore
12 Information Technology Stocks Moving In Thursday's Intraday SessionAmplitech Group, Inc.Series A - Benzinga
DNA X, Inc. (SONM) Reports Q1 2026 Financial Results, Completes Mobile Business Sale, and Focuses on AI Crypto Trading Platform - Minichart
DNA X, Inc. Reports First Quarter 2026 Financial Results - Scott Coop
DNA X: Q1 Earnings Snapshot - kare11.com
DNA X, Inc. 1Q 2026: Revenue $0 Net income $6.34M, EPS $5.01— 10-Q Summary - TradingView
SONM: Q1 2026 net income surged to $6.3M on asset sale, but core crypto trading posted a $3.9M loss - TradingView
DNA X, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
DNA X (NASDAQ: SONM) exits handset business, leans on crypto platform and new funding - Stock Titan
SONM: Exited legacy business, posted strong net income, and pivoted to AI crypto trading platform - TradingView
DNA X (NASDAQ: SONM) exits phones, pivots to AI crypto trading - Stock Titan
FMAC Price Today: Future Money Acquisition Corporation Stock Price, Quote & Chart | MEXC - MEXC Exchange
AUC Price Today: ATIF Holdings Limited Stock Price, Quote & Chart | MEXC - MEXC
Stock Market News for May 20, 2026 - Stock Titan
Why Is DNA Brands, Inc. (DNAX) Stock Down Today? - Meyka
SONM Stock Price, Quote & Chart | DNA X INC (NASDAQ:SONM) - ChartMill
DNA X, Inc. Delays Quarterly Filing After Asset Sale - TipRanks
12 Information Technology Stocks Moving In Friday's After-Market Session - Benzinga
DNA X (SONM) delays Q1 2026 10-Q after Legacy Business sale; expects $3.6M loss - Stock Titan
Dna Brands Inc (OP: DNAX - The Chronicle-Journal
DNA X (SONM): Laurence Lytton discloses 120,357 shares (8.1%) - Stock Titan
How DNA's Double Helix Structure Was Discovered - Britannica
Takara Bio Inc stock (JP3463000004): Featured in expanding DNA polymerase and cell culture media mar - AD HOC NEWS
Lotus unveils Focus 2030 strategy with new hybrid-V8 supercar and X-Hybrid tech for global growth. - Pluang
Lotus Unveils Focus 2030Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar - The Manila Times
Lotus Unveils Focus 2030 – Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar - mykxlg.com
About Us | Oil & Gas JournalLotus Unveils Focus 2030 – Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar - FinancialContent
DNA X Inc. (SONM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price, News, Quote & History - Yahoo Finance
[8-K] Ginkgo Bioworks Holdings, Inc. Reports Material Event - Stock Titan
Central Bancompany, Inc. Announces Dividend Declaration and Reports May 2026 SEC Filing Results - Minichart
What DNA X (SONM) subscription metrics reveal about retention | Q3 2024: Profit Exceeds ViewsBuy Rating - newser.com
SONM | DNA X, Inc. Common Insider Trading - Quiver Quantitative
SONM Forecast, Price Target & Analyst Ratings | DNA X INC (NASDAQ:SONM) - ChartMill
[10-K/A] DNA X, Inc. Amends Annual Report - Stock Titan
[8-K] DNA X, Inc. Reports Material Event - Stock Titan
Ginkgo Bioworks will take investor questions after May 7 results - Stock Titan
Ansa Biotechnologies to Showcase Breakthrough DNA Synthesis Technology Backed by Industry’s Only On-Time Guarantee at SynBioBeta 2026 Conference - 01net
Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine - Business Wire
SONM Price Today: DNA X, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
SONM (DNA X) reports narrower than projected Q3 2024 loss, with shares rising 7.75 percent in today’s session.Viral Momentum Stocks - newser.com
INSP (Inspire Medical Systems Inc.) Q4 2025 EPS beats estimates by wide margin even as shares dip slightly today. - Cổng thông tin điện tử tỉnh Lào Cai
SONM (DNA X) tops Q3 2024 EPS forecasts, lifting shares nearly 10 percent on positive investor sentiment.Management Guidance - Cổng thông tin điện tử tỉnh Lào Cai
SONM SEC FilingsDNA X 10-K, 10-Q, 8-K Forms - Stock Titan
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - 富途牛牛
DNA X, Inc. Reports 2025 Financial Results, Completes Asset Sale, and Focuses on Growth of Cryptocurrency Trading Platform - Minichart
12 Information Technology Stocks Moving In Wednesday's After-Market Session - Benzinga
DNA X, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
DNA X (NASDAQ: SONM) outlines crypto shift, tiny scale and going‑concern risk - Stock Titan
DNA X, Inc. Reports Full Year 2025 Financial Results - TradingView
Dna X Inc (SONM) 財務データ
収益
当期純利益
現金流量
EPS
0.83%
1.66%
大文字化:
|
ボリューム (24 時間):